Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Opal Ventures is a venture capital firm based in the United States, dedicated to supporting health tech startups. Founded with a thesis-driven approach, the firm focuses on early-stage investments, particularly in the pre-seed stage, and manages a portfolio of 12 companies.
Opal Ventures invests between $100,000 and $200,000 in health tech startups, emphasizing a high-conviction approach. The firm often provides the first check into promising ventures, supporting companies that aim to transform healthcare through technology.
Notable portfolio companies include Orchestra Health, a clinical care transition platform for surgery; Vitract, a gut microbiome testing and research company; and Weave, an AI platform designed to streamline the drug development process. Other companies include Well Theory, focused on reversing the autoimmune epidemic, and Astron Health, which democratizes access to precision oncology interventions.
Submit your pitch through their website's contact form for consideration.
Yes, Opal Ventures often leads rounds, particularly in the pre-seed stage, providing initial funding to promising health tech startups.
The firm typically focuses on early-stage investments and may consider follow-on investments based on the performance and needs of their portfolio companies.
Specific details about the size of Opal Ventures' current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.